{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:40:38Z","timestamp":1792093238026,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-coding mutations in the <jats:italic>TERT<\/jats:italic> promoter (<jats:italic>TERT<\/jats:italic>p), typically at one of two bases \u2212124 and \u2212146 bp upstream of the start codon, are among the most prevalent driver mutations in human cancer. Several additional recurrent <jats:italic>TERT<\/jats:italic>p mutations have been reported but their functions and origins remain largely unexplained. Here, we show that atypical <jats:italic>TERT<\/jats:italic>p mutations arise secondary to canonical <jats:italic>TERT<\/jats:italic>p mutations in a two-step process. Canonical <jats:italic>TERT<\/jats:italic>p mutations create de novo binding sites for ETS family transcription factors that induce favourable conditions for DNA damage formation by UV light, thus creating a hotspot effect but only after a first mutational hit. In agreement, atypical <jats:italic>TERT<\/jats:italic>p mutations co-occur with canonical driver mutations in large cancer cohorts and arise subclonally specifically on the <jats:italic>TERT<\/jats:italic>p driver mutant chromosome homolog of melanoma cells treated with UV light in vitro. Our study gives an in-depth view of <jats:italic>TERT<\/jats:italic>p mutations in cancer and provides a mechanistic explanation for atypical <jats:italic>TERT<\/jats:italic>p mutations.<\/jats:p>","DOI":"10.1038\/s41467-024-54158-5","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T10:32:40Z","timestamp":1731925960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mechanistic basis of atypical TERT promoter mutations"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-7879","authenticated-orcid":false,"given":"Kerryn","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-2505","authenticated-orcid":false,"given":"Vinod Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8590-1195","authenticated-orcid":false,"given":"Alan","family":"B\u00e4ckerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1836-6660","authenticated-orcid":false,"given":"Linnea","family":"\u00d6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8984-8064","authenticated-orcid":false,"given":"Markus","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M.","family":"Soczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hoberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0231-3815","authenticated-orcid":false,"given":"Tom","family":"Luijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Van den Eynden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-999X","authenticated-orcid":false,"given":"Jennifer","family":"Doudna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4243-0191","authenticated-orcid":false,"given":"Anders","family":"St\u00e5hlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1400-0119","authenticated-orcid":false,"given":"Erik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"54158_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1158\/1541-7786.MCR-16-0003","volume":"14","author":"RJ Bell","year":"2016","unstructured":"Bell, R. J. et al. Understanding TERT promoter mutations: a common path to immortality. Mol. Cancer Res 14, 315\u2013323 (2016).","journal-title":"Mol. Cancer Res"},{"key":"54158_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959\u2013961 (2013).","journal-title":"Science"},{"key":"54158_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957\u2013959 (2013).","journal-title":"Science"},{"key":"54158_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ijc.30735","volume":"141","author":"B Heidenreich","year":"2017","unstructured":"Heidenreich, B. & Kumar, R. Altered TERT promoter and other genomic regulatory elements: occurrence and impact. Int J. Cancer 141, 867\u2013876 (2017).","journal-title":"Int J. Cancer"},{"key":"54158_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2016.11.002","volume":"771","author":"B Heidenreich","year":"2017","unstructured":"Heidenreich, B. & Kumar, R. TERT promoter mutations in telomere biology. Mutat. Res Rev. Mutat. Res 771, 15\u201331 (2017).","journal-title":"Mutat. Res Rev. Mutat. Res"},{"key":"54158_CR6","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ijc.33750","volume":"149","author":"S Rachakonda","year":"2021","unstructured":"Rachakonda, S., Hoheisel, J. D. & Kumar, R. Occurrence, functionality and abundance of the TERT promoter mutations. Int J. Cancer 149, 1852\u20131862 (2021).","journal-title":"Int J. Cancer"},{"key":"54158_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-021-00371-z","volume":"21","author":"K Elliott","year":"2021","unstructured":"Elliott, K. & Larsson, E. Non-coding driver mutations in human cancer. Nat. Rev. Cancer 21, 500\u2013509 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"54158_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.aab0015","volume":"348","author":"RJ Bell","year":"2015","unstructured":"Bell, R. J. et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 348, 1036\u20131039 (2015).","journal-title":"Science"},{"key":"54158_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33099-x","volume":"13","author":"CJ Barger","year":"2022","unstructured":"Barger, C. J. et al. Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer. Nat. Commun. 13, 5430 (2022).","journal-title":"Nat. Commun."},{"key":"54158_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jmoldx.2020.11.003","volume":"23","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. A pan-cancer study of somatic TERT promoter mutations and amplification in 30,773 tumors profiled by clinical genomic sequencing. J. Mol. Diagn. 23, 253\u2013263 (2021).","journal-title":"J. Mol. Diagn."},{"key":"54158_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med 23, 703\u2013713 (2017).","journal-title":"Nat. Med"},{"key":"54158_CR12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ijc.31780","volume":"144","author":"JJ Andres-Lencina","year":"2019","unstructured":"Andres-Lencina, J. J. et al. TERT promoter mutation subtypes and survival in stage I and II melanoma patients. Int J. Cancer 144, 1027\u20131036 (2019).","journal-title":"Int J. Cancer"},{"key":"54158_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ng.3141","volume":"46","author":"NJ Fredriksson","year":"2014","unstructured":"Fredriksson, N. J., Ny, L., Nilsson, J. A. & Larsson, E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet 46, 1258\u20131263 (2014).","journal-title":"Nat. Genet"},{"key":"54158_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4401","volume":"5","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich, B. et al. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat. Commun. 5, 3401 (2014).","journal-title":"Nat. Commun."},{"key":"54158_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","volume":"34","author":"AH Shain","year":"2018","unstructured":"Shain, A. H. et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer Cell 34, 45\u201355 e44 (2018).","journal-title":"Cancer Cell"},{"key":"54158_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre, J. et al. Frequency of TERT promoter mutations in human cancers. Nat. Commun. 4, 2185 (2013).","journal-title":"Nat. Commun."},{"key":"54158_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","volume":"51","author":"DS Huang","year":"2015","unstructured":"Huang, D. S. et al. Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. Eur. J. Cancer 51, 969\u2013976 (2015).","journal-title":"Eur. J. Cancer"},{"key":"54158_CR18","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1073\/pnas.86.14.5315","volume":"86","author":"MM Becker","year":"1989","unstructured":"Becker, M. M., Wang, Z., Grossmann, G. & Becherer, K. A. Genomic footprinting in mammalian cells with ultraviolet light. Proc. Natl Acad. Sci. USA 86, 5315\u20135319 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54158_CR19","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1073\/pnas.1706522114","volume":"114","author":"J Hu","year":"2017","unstructured":"Hu, J., Adebali, O., Adar, S. & Sancar, A. Dynamic maps of UV damage formation and repair for the human genome. Proc. Natl Acad. Sci. USA 114, 6758\u20136763 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54158_CR20","first-page":"1798","volume":"12","author":"GP Pfeifer","year":"1992","unstructured":"Pfeifer, G. P., Drouin, R., Riggs, A. D. & Holmquist, G. P. Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol. Cell Biol. 12, 1798\u20131804 (1992).","journal-title":"Mol. Cell Biol."},{"key":"54158_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1073\/pnas.85.3.654","volume":"85","author":"Z Wang","year":"1988","unstructured":"Wang, Z. & Becker, M. M. Selective visualization of gene structure with ultraviolet light. Proc. Natl Acad. Sci. USA 85, 654\u2013658 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54158_CR22","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1073\/pnas.1606667113","volume":"113","author":"P Mao","year":"2016","unstructured":"Mao, P., Smerdon, M. J., Roberts, S. A. & Wyrick, J. J. Chromosomal landscape of UV damage formation and repair at single-nucleotide resolution. Proc. Natl Acad. Sci. USA 113, 9057\u20139062 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54158_CR23","doi-asserted-by":"publisher","first-page":"e1006773","DOI":"10.1371\/journal.pgen.1006773","volume":"13","author":"NJ Fredriksson","year":"2017","unstructured":"Fredriksson, N. J. et al. Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature. PLoS Genet 13, e1006773 (2017).","journal-title":"PLoS Genet"},{"key":"54158_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05064-0","volume":"9","author":"P Mao","year":"2018","unstructured":"Mao, P. et al. ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma. Nat. Commun. 9, 2626 (2018).","journal-title":"Nat. Commun."},{"key":"54158_CR25","doi-asserted-by":"publisher","first-page":"e1007849","DOI":"10.1371\/journal.pgen.1007849","volume":"14","author":"K Elliott","year":"2018","unstructured":"Elliott, K. et al. Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers. PLoS Genet 14, e1007849 (2018).","journal-title":"PLoS Genet"},{"key":"54158_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38266-2","volume":"14","author":"K Elliott","year":"2023","unstructured":"Elliott, K., Singh, V. K., Bostrom, M. & Larsson, E. Base-resolution UV footprinting by sequencing reveals distinctive damage signatures for DNA-binding proteins. Nat. Commun. 14, 2701 (2023).","journal-title":"Nat. Commun."},{"key":"54158_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38265-3","volume":"14","author":"K Selvam","year":"2023","unstructured":"Selvam, K., Sivapragasam, S., Poon, G. M. K. & Wyrick, J. J. Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing. Nat. Commun. 14, 2702 (2023).","journal-title":"Nat. Commun."},{"key":"54158_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"APG Consortium","year":"2017","unstructured":"Consortium, A. P. G. AACR project GENIE: powering precision medicine through an international consortium. Cancer Discov. 7, 818\u2013831 (2017).","journal-title":"Cancer Discov."},{"key":"54158_CR29","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl Acad. Sci. USA 110, 6021\u20136026 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54158_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.3781","volume":"49","author":"FP Barthel","year":"2017","unstructured":"Barthel, F. P. et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat. Genet 49, 349\u2013357 (2017).","journal-title":"Nat. Genet"},{"key":"54158_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"54158_CR32","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/ncb3240","volume":"17","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Non-canonical NF-kappaB signalling and ETS1\/2 cooperatively drive C250T mutant TERT promoter activation. Nat. Cell Biol. 17, 1327\u20131338 (2015).","journal-title":"Nat. Cell Biol."},{"key":"54158_CR33","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/2159-8290.CD-21-1547","volume":"12","author":"TJ Pugh","year":"2022","unstructured":"Pugh, T. J. et al. AACR project GENIE: 100,000 cases and beyond. Cancer Discov. 12, 2044\u20132057 (2022).","journal-title":"Cancer Discov."},{"key":"54158_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34746-z","volume":"13","author":"M Bostrom","year":"2022","unstructured":"Bostrom, M. & Larsson, E. Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer. Nat. Commun. 13, 7023 (2022).","journal-title":"Nat. Commun."},{"key":"54158_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1373\/clinchem.2017.284257","volume":"64","author":"AJ Colebatch","year":"2018","unstructured":"Colebatch, A. J. et al. Optimizing amplification of the GC-Rich TERT promoter region using 7-Deaza-dGTP for droplet digital PCR quantification of TERT promoter mutations. Clin. Chem. 64, 745\u2013747 (2018).","journal-title":"Clin. Chem."},{"key":"54158_CR36","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1021\/ja101252n","volume":"132","author":"KW Lim","year":"2010","unstructured":"Lim, K. W. et al. Coexistence of two distinct G-quadruplex conformations in the hTERT promoter. J. Am. Chem. Soc. 132, 12331\u201312342 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"54158_CR37","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nprot.2017.006","volume":"12","author":"A Stahlberg","year":"2017","unstructured":"Stahlberg, A. et al. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing. Nat. Protoc. 12, 664\u2013682 (2017).","journal-title":"Nat. Protoc."},{"key":"54158_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00432-021-03536-3","volume":"147","author":"B Powter","year":"2021","unstructured":"Powter, B. et al. Human TERT promoter mutations as a prognostic biomarker in glioma. J. Cancer Res Clin. Oncol. 147, 1007\u20131017 (2021).","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"54158_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"54158_CR40","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain, A. H. et al. The genetic evolution of melanoma from precursor lesions. N. Engl. J. Med. 373, 1926\u20131936 (2015).","journal-title":"N. Engl. J. Med."},{"key":"54158_CR41","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1101\/gad.269498.115","volume":"29","author":"JL Stern","year":"2015","unstructured":"Stern, J. L., Theodorescu, D., Vogelstein, B., Papadopoulos, N. & Cech, T. R. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers. Genes Dev. 29, 2219\u20132224 (2015).","journal-title":"Genes Dev."},{"key":"54158_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"54158_CR43","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"54158_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"54158_CR45","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/clinchem\/hvac136","volume":"68","author":"T Osterlund","year":"2022","unstructured":"Osterlund, T., Filges, S., Johansson, G. & Stahlberg, A. UMIErrorCorrect and UMIAnalyzer: software for consensus read generation, error correction, and visualization using unique molecular identifiers. Clin. Chem. 68, 1425\u20131435 (2022).","journal-title":"Clin. Chem."},{"key":"54158_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward, N. K. et al. Whole-genome landscapes of major melanoma subtypes. Nature 545, 175\u2013180 (2017).","journal-title":"Nature"},{"key":"54158_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"54158_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1200\/CCI.20.00108","volume":"5","author":"R Kundra","year":"2021","unstructured":"Kundra, R. et al. OncoTree: A cancer classification system for precision oncology. JCO Clin. Cancer Inf. 5, 221\u2013230 (2021).","journal-title":"JCO Clin. Cancer Inf."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54158-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T02:05:19Z","timestamp":1732241119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54158-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54158"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54158-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S. is a co-inventor of the SiMSen-Seq technology that is patent protected (U.S. Serial No.:15\/552,618). A.S. declares stock ownership in Tulebovaasta, Iscaff Pharma and SiMSen Diagnostics, and is a board member of Tulebovaasta. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9965"}}